Acceleration of nitric oxide (NO) release from FK409, a spontaneous NO releaser, in the presence of sulfhydryl-bearing compounds

被引:11
作者
Fukuyama, S [1 ]
Hirasawa, Y [1 ]
Cox, D [1 ]
Koda, S [1 ]
Kita, Y [1 ]
机构
[1] FUJISAWA PHARMACEUT CO LTD,NEW DRUG RES LABS,YODOGAWA KU,OSAKA 532,JAPAN
关键词
FK409; isosorbide dinitrate; nitric oxide; L-cysteine; antiplatelet activity;
D O I
10.1023/A:1016248124104
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose: Recently, we have reported that FK409 spontaneously releases nitric oxide (NO) in solution. In the present study, the influence of L-cysteine (Cys) and glutathione (CSH), which are typical sulfhydryl group-bearing compounds, on NO release from FK409 and biological action of FK409 was examined. Methods. We evaluated the effects of Cys and GSH on NO release from FK409 by nitrite analysis or detection with a chemiiluminesence analyzer. In a biological study, the influence of Cys on inhibition of rat platelet aggregation of FK409 was investigated. In addition, the above mentioned characteristics of FK409 were compared with those of isosorbide dinitrate (ISDN). Results. FK409 decomposed spontaneously with generation of nitrite in solution. Both Cys and GSH accelerated decomposition of FK409 and nitrite generation from FK409 in a concentration-dependent manner. When the NO levels in the headspace of FK409 solutions (0.5 mM) reached equilibrium with and without 25 mM Cys, the constant rate for NO release from FK409 in the presence of Cys was 13 times larger than that in the absence of Cys. In biological study, FK409 (100 mu M) showed 56 and 90% inhibition of rat platelet aggregation in the absence and presence of 10 mM Cys, respectively, whereas ISDN (100 mu M) showed 10 and 23% inhibition, respectively. Conclusions. Decomposition of FK409 with generation of NO is spontaneous, and is accelerated in the presence of sulfhydryl group-bearing compounds, thereby potentiating the biological action of FK409.
引用
收藏
页码:1948 / 1952
页数:5
相关论文
共 15 条
[1]  
BORN GVR, 1963, J PHYSIOL-LONDON, V168, P178, DOI 10.1113/jphysiol.1963.sp007185
[2]  
CHUNG SJ, 1992, J PHARMACOL EXP THER, V260, P652
[3]   A COMMON ENZYME MAY BE RESPONSIBLE FOR THE CONVERSION OF ORGANIC NITRATES TO NITRIC-OXIDE IN VASCULAR MICROSOMES [J].
CHUNG, SJ ;
FUNG, HL .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 185 (03) :932-937
[6]   CORRELATION BETWEEN NITRIC-OXIDE FORMATION DURING DEGRADATION OF ORGANIC NITRATES AND ACTIVATION OF GUANYLATE-CYCLASE [J].
FEELISCH, M ;
NOACK, EA .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1987, 139 (01) :19-30
[7]   A NEW NITRIC-OXIDE (NO) RELEASER - SPONTANEOUS NO RELEASE FROM FK409 [J].
FUKUYAMA, S ;
KITA, Y ;
HIRASAWA, Y ;
SATO, A ;
MOROKOSHI, N ;
KODA, S ;
YASUDA, T ;
OKA, S ;
SAKURAI, H .
FREE RADICAL RESEARCH, 1995, 23 (05) :443-452
[8]   FK409, A NOVEL VASODILATOR ISOLATED FROM THE ACID-TREATED FERMENTATION BROTH OF STREPTOMYCES-GRISEOSPOREUS .1. TAXONOMY, FERMENTATION, ISOLATION, AND PHYSICOCHEMICAL AND BIOLOGICAL CHARACTERISTICS [J].
HINO, M ;
IWAMI, M ;
OKAMOTO, M ;
YOSHIDA, K ;
HARUTA, H ;
OKUHARA, M ;
HOSODA, J ;
KOHSAKA, M ;
AOKI, H ;
IMANAKA, H .
JOURNAL OF ANTIBIOTICS, 1989, 42 (11) :1578-1583
[9]  
IGNARRO LJ, 1981, J PHARMACOL EXP THER, V218, P739
[10]   SPONTANEOUS NITRIC-OXIDE RELEASE ACCOUNTS FOR THE POTENT PHARMACOLOGICAL ACTIONS OF FK409 [J].
KITA, Y ;
HIRASAWA, Y ;
MAEDA, K ;
NISHIO, M ;
YOSHIDA, K .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1994, 257 (1-2) :123-130